It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Objective
Relative one-year cancer survival rates in the Baltic states are lower than the European mean; in the Nordic countries they are higher than the mean. This study investigated the likelihood of General Practitioners (GPs) investigating or referring patients with a low but significant risk of cancer in these two regions, and how this was affected by GP demographics.
DesignA survey of GPs using clinical vignettes.
SettingGeneral Practice in Denmark, Estonia, Finland, Latvia, Lithuania, Norway, and Sweden.
SubjectsGeneral Practitioners.
Outcome measuresA regional comparison of GPs’ stated immediate diagnostic actions (whether or not they would perform a key diagnostic test and/or refer to a specialist) for patients with a low but significant risk of cancer (between 1.2 and 3.6%).
ResultsOf the 427 GPs that completed the questionnaire, those in the Baltic states, and GPs that were more experienced, were more likely to arrange a key diagnostic test and/or refer their patient to a specialist than those in Nordic Countries or who were less experienced (p < 0.001 for both measures). Neither GP sex nor practice location within a country showed a significant association with these measures.
ConclusionWhile relative one-year cancer survival rates are lower in the Baltic states than in four Nordic countries, we found no evidence that this is due to their GPs’ reluctance to take immediate diagnostic action, as GPs in the Baltic states were more likely to investigate and/or refer at the first consultation. Research on patient and secondary care factors is needed to explain the survival differences.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details









1 Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia
2 Family Medicine Residency, University of Tartu, Tartu, Estonia
3 Department of Family Medicine, Riga Stradiņš University, Riga, Latvia
4 Department of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway
5 Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland; Wellbeing Services County of Pirkanmaa, Tampere, Finland
6 Department of Family Medicine, Lithuanian University of Health Sciences, Kaunas, Lithuania
7 Department of Family Medicine, Riga Stradiņš University, Riga, Latvia; Department of Medicine and Optometry, Faculty of Health and Life Sciences, Linnaeus University, Växjö, Sweden
8 Research Unit for General Practice, Aarhus, Denmark; Department of Clinical Medicine, University Clinic for Innovative Patient Pathways, Aarhus University, Aarhus, Denmark
9 Department of Family Medicine, Riga Stradiņš University, Riga, Latvia; Department for Health, University of Bath, Bath, UK; Institute of Primary Health Care Bern (BIHAM), University of Bern, Bern, Switzerland